CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 33 enrolled
Drug / intervention
Platelet Rich Plasma Injectionbiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05080075
NCT05080075Early Ph 1Completed
CompareCT.gov

Platelet Rich Plasma in Knee Osteoarthritis: Establishing Clinical Guidelines to Predict and Maximize Outcomes

University of Toledo Health Science Campus·interventional·Posted Oct 15, 2021·Updated May 7, 2024

In Brief

A Early Phase 1 clinical trial evaluating Platelet Rich Plasma Injection for Knee Osteoarthritis. Completed, enrolled 33 participants across 1 site.

Detailed Summary

In this study, the investigators will be performing intra-articular platelet rich plasma (PRP) injections for patients experiencing pain related to osteoarthritis of the knee. The investigators will be following clinical outcomes, and how they relate to concentrations of the PRP samples as well as following opioid and emergency room utilization pre and post-injection.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKnee Osteoarthritis
CountriesUnited States
Collaborators--

Timeline

Early Ph 1CompletedFinished
20222023202420252026
First PostedOct 15, 2021
Enrollment StartDec 2, 2021
Primary CompletionNov 6, 2023
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 4.7 years ago

Interventions

Platelet Rich Plasma Injectionbiological

Research participants own blood will be used to prepare the platelet rich plasma injectate, which will be injected into the affected knee using ultrasound guidance.